Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27486603 | 0.89 | CES2 (0.52) | ALDH1A1CES2TDP1CYP19A1CA2 | |
| SCHEMBL27436928 | 0.84 | PDE4A (0.45) | ALDH1A1CYP2C19L3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL27434149 | 0.83 | CES2 (0.58) | ALDH1A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4285852 | 0.80 | NFE2L2 (0.48) | ALDH1A1CYP2C19L3MBTL1CES1CES2 | |
| SCHEMBL27536908 | 0.79 | KAT6A (0.44) | PDE4APDE4BPDE4CPDE4DPTGS2 | |
| SCHEMBL262233 | 0.76 | CES2 (0.43) | ALDH1A1CYP2C19L3MBTL1CES1CES2 | |
| SCHEMBL6801638 | 0.76 | CES2 (0.43) | ALDH1A1CYP2C19L3MBTL1CES1CES2 | |
| SCHEMBL262234 | 0.76 | CES2 (0.43) | ALDH1A1CYP2C19L3MBTL1CES1CES2 | |
| SCHEMBL7607185 | 0.76 | CES1 (0.39) | ALDH1A1CYP2C19L3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL4713673 | 0.76 | RECQL (0.46) | ALDH1A1CYP2C19L3MBTL1CES1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112470046-A | Retardation film and method for producing same | 林特琅普股份有限公司 | 2021-03-09 | — | — | CN | claimed |
| CN-104603643-A | Methods of making and articles comprising a yellowing resistant polycarbonate composition | SABIC INNOVATIVE PLASTICS IP | 2015-05-06 | — | — | CN | claimed |
| CN-104136423-A | Ribonucleotide reductase inhibitors and methods of use | HOPE CITY | 2014-11-05 | — | — | CN | claimed |
| CN-102285951-A | Luteolin derivative and application thereof to preventing and treating cardiovascular disease | — | 2011-12-21 | — | — | CN | claimed |
| EP-1663915-B1 | METHOD FOR THE PRODUCTION OF [18F] FLUORIDE-MARKED AROMATIC L-AMINO ACIDS | UNIV EBERHARD KARLS (DE) | 2009-12-02 | — | — | EP | claimed |
| US-7297788-B2 | Regioselective hydroxylation, functionalisation and protection of spirolactams | LABORATORIOS DEL DR. ESTEVE. S.A. (ES) | 2007-11-20 | — | — | US | claimed |
| US-20050261492-A1 | Regioselective hydroxylation, functionalisation and protection of spirolactams | LABORATORIES DEL DR. ESTEVE, S.A. (ES) | 2005-11-24 | — | — | US | claimed |
| EP-1598336-A1 | Regioselective hydroxylation, functionalisation and protection of spirolactams | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2005-11-23 | — | — | EP | claimed |
| JP-55031851-A | — | — | None | — | — | JP | disclosed |
| US-12002595-B2 | Separation of metal ions by liquid-liquid extraction | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-04 | — | — | US | disclosed |
| US-20220160904-A1 | CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-05-26 | — | — | US | disclosed |
| CN-114026175-A | Thermoplastic resin composition | 帝人株式会社 | 2022-02-08 | — | — | CN | disclosed |
| US-11235076-B2 | Chelating platform for delivery of radionuclides | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-02-01 | — | — | US | disclosed |
| CN-113474691-A | Optical layered body and method for producing same | 林特琅普股份有限公司 | 2021-10-01 | — | — | CN | disclosed |
| EP-0216385-A2 | Antibacterial compounds | Takeda Chemical Industries, Ltd. (JP) | 1987-04-01 | — | — | EP | disclosed |
| WO-1986005183-A1 | ANTIBACTERIAL COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1986-09-12 | — | — | WO | disclosed |
| EP-0164122-A2 | Cephem compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-12-11 | — | — | EP | disclosed |
| EP-0164113-A2 | 3-pyrazolo(1,5-a)pyridinium cephem compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-12-11 | — | — | EP | disclosed |
| EP-0160252-A2 | Antibacterial compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-11-06 | — | — | EP | disclosed |
| JP-S5531851-A | FLAME-RETARDANT RESIN COMPOSITION | FUJITSU LTD | 1980-03-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261492-A1 | Regioselective hydroxylation, functionalisation and protection of spirolactams | POR, CYP51A1, CYP17A1 | ALDH1A1 82/4885CYP2C19 7/4885L3MBTL1 4825/4885 |
| US-11235076-B2 | Chelating platform for delivery of radionuclides | SLC40A1, TFRC, SLC39A14 | ALDH1A1 4561/4885CYP2C19 4680/4885L3MBTL1 2354/4885 |
| US-20220160904-A1 | CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES | SLC40A1, TFRC, SLC39A14 | ALDH1A1 4561/4885CYP2C19 4680/4885L3MBTL1 2354/4885 |
| US-12002595-B2 | Separation of metal ions by liquid-liquid extraction | SLC39A14, SLC39A11, SLC39A7 | ALDH1A1 4783/4885CYP2C19 4298/4885L3MBTL1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.